Duration of chemotherapy for advances NSCLC: A phase III randomized trial of 3 versus 6 courses of mitomycin, vinblastine, cisplatin (MVP). - Smith,I.E.; O'Brien,M.ER.; Norton,A.; Ashley,S.; Webb,A.; Nicolson,M.; Hickish,T.; Talbot,T.; Mansi,J. (Proc Am Soc Clin Oncol, 1998)